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ABSTRACT: We wished to evaluate the pulmonary defence capacity against com-
mon bacterial infections in patients with pulmonary tuberculosis.
Bactericidal activity against Staphylococcus aureus of bronchoalveolar lavage flu-
ids (cell-free supernatants) of patients with active (n=13) and inactive pulmonary
tuberculosis (n=8), and normal individuals (n=6), were studied.
The 2 and 4 h bactericidal activities were higher than the 0 h activity in lavage
fluids of healthy subjects and patients with inactive pulmonary tuberculosis. Active
tuberculous lavage fluids were equally competent in their bactericidal activity against
S. aureus at 0 and 2 h, but a reduced S. aureus hilling was seen at 4 h of incuba-
tion. Estimation of total phospholipid levels revealed no significant difference
between the various lavage fluids. This reduced hilling of S. aureus howed a rela-
tionship with the cellular components (lymphocytes and macrophages) of active
tuberculous lavage fluids. A reduced hilling was associated with no lymphocytic
alveolitis, and an increased hilling with lymphocytic alveolitis.
This study suggests that alveolar lining material of patients with active pulmonary
tuberculosis has less bactericidal activity against bacterial infections, such as S.
aureus.
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Alveolar macrophages are involved in the defence
against pathogens and elimination of inhaled dusts. These
cells reside in a lipid-rich alveolar lining fluid contain-
ing pulmonary surfactant, produced by alveolar type-II
epithelial cells.
Pulmonary surfactant has been known to have immuno-
regulatory functions [1-4]. It has been shown that alve-
olar lining material promotes superoxide production,
chemotaxis and the tumoricidal activity of monocytes
and macrophages [1-3]. Moreover, whole and purified
surfactant lipids of alveolar lavage material have been
shown to suppress the human lymphocyte proliferation
to mitogen [4].
Bacterial infection is associated with chronic respira-
tory diseases [5]. Bactericidal activity has been shown
in crude preparations of lung lavage material [6, 7].
Several Gram-positive bacteria are susceptible to alve-
olar lining material. Phospholipids, especially the lysophos-
phatidylcholine of the surfactant, possess this antibacterial
activity [7].
To understand the pulmonary defence mechanisms
against common bacterial infections, such as S. aureus,
in patients with pulmonary tuberculosis, we examined
bactericidal activity in lavage samples from patients with
active and inactive pulmonary tuberculosis, and healthy
subjects. We used S. aureus as an indicator micro-
organism.
Materials and methods
Study subjects
Subjects included in this study were 13 patients with
active pulmonary tuberculosis (7 nonsmokers and 6 smok-
ers), 8 patients with inactive pulmonary tuberculosis
(cured) (4 nonsmokers and 4 smokers), and 6 normal
subjects (all nonsmokers).
Active tuberculosis patients (ATB)
These patients were drawn from among those attend-
ing the Tuberculosis Research Centre, Madras, during
1987, with respiratory symptoms and radiographic abnor-
m lities suggestive of pulmonary tuberculosis. At the
time of initial assessment, all patients (n=41) had six
sputum smears negative for acid-fast bacilli (APB). These
patients had respiratory symptoms of less than 6 months
duration, and all had minimal radiographic abnormali-
ties in one of the upper zones. None had received any
antituberculosis treatment in the past. Among these
patients, there were 13 patients whose sputa or lavage
fluids had shown growth of Mycobacterium tuberculosis,
and they were classified as active pulmonary tuberculo-
sis patients.
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Cured (inactive) tuberculosis patients (ITB)
These patients (n=8) had received antituberculosis treat-
ment elsewhere, at least one year prior to our evalua-
tion. They presented at our centre with recurrence of
symptoms. Most of these patients (6 of the 8) had
received a full course of antituberculosis treatment, main-
ly of long-term (12-18 months) duration, and two had
received a short course of chemotherapy that included
rifampicin. All had respiratory symptoms, particularly
cough or breathlessness, varying from 6 months to one
year duration, and radiographic abnormalities suggestive
of healed tuberculosis in upper or mid-zones. These
patients had sputum smears negative for AFB at the time
of evaluation. Sputa and lavage cultures were also nega-
tive for M. tuberculosis.
Normal subjects
These subjects (n=6) had no abnormalities in chest X-
rays and pulmonary functions.
Fibreoptic bronchoscopy and bronchoalveolar lavage
(BAL)
All subjects underwent fibreoptic bronchoscopy and
BAL. The procedures for fibreoptic bronchoscopy and
BAL have been described elsewhere [8, 9]. The BAL
fluids were centrifuged at 1,500 rpm for 10 min. The
cell-free supernatants were stored at -20°C. Alveolar
cells were suspended in RPMI-1640 (Gibco, USA) tis-
sue culture medium, supplemented with 10% foetal calf
serum, and used for total and differential cell counts. All
of the cell-free supernatants were concentrated threefold
(3x) in a freeze-dryer (Birchover Instruments Ltd, UK)
and used for bactericidal assay against S. ureus and
phospholipid estimation.
Differential count
Ten microlitres of this cell suspension, containing 5x104
cells, was transferred to a clean dry glass slide and a
smear was made.Smears of alveolar cells of the patients
and normal subjects were stained, using modified Wright-
Giemsa stain (Diff-Quick, American Scientific Pro-
ducts, USA). A total of 300 cells was counted for each
smear.
Staphylococcus aureus
The Staphylococcus aureus strain used in this study
was isolated from a tropical pulmonary eosinophilia
patient [10], and was seen to be resistant to 100 µg·ml-1
lysozyme for 4 h. Log phase cultures of S. aureus were
prepared using tryptic soy broth (Difco, USA), by incu-
bating at 37°C for 18 h. The bacteria were washed three
times in phosphate buffered saline (PBS), and counted
in a bacterial-counting chamber (Thoma, Weber Scientific
International Ltd, UK), and adjusted to 4x107·ml-1 PBS.
Smears of this suspension were stained with Gram stain
for confirmation.
Bactericidal assay against S. aureus
The method described by CONROD and YONEDA [7]
was followed. Briefly, 2x106 S. aureus in 50 µl PBS
were mixed with 250 µl of threefold concentrated cell-
free supernatants of the alveolar lavage samples or PBS
(control), and incubated at 37°C for 0, 2 and 4 h. After
the incubation periods, the samples were subjected to
tenfold dilutions. One hundred microlitres of the dilu-
ted samples were plated on tryptic soy agar plates (Difco,
USA) and streaked to enumerate the colony-forming units
(cfu).
The plates were incubated at 37°C for 24 h, and the
number of individual cfu were counted. For each sam-
ple, triplicates were made and the variation was less than
10%. The percentage bactericidal activity against S.
aureus of the different lavage samples and for the vari-
ous time-points were calculated based on the number of cfu.
Anti-staphylococcal antibody in the lavage samples
Staphylococcal agglutination test was performed to
determine the presence of antibody against staphyloc-
occi in the lavage samples. Threefold concentrated lavage
samples were serially diluted (twofold) in PBS. A 1%
susp nsion of heat-killed S. aureus was added to each
sample and incubated at 37°C. Readings were taken
after 24 h.
Phospholipid estimation
Phospholipid estimation was carried out, using the
method described for serum phospholipid [11]. Threefold
concentrated (3x) lavage samples were used to estimate
the phospholipid level, and expressed as mg.dl-1 of lx
lavage fluids (unconcentrated).
Briefly, 0.2 ml of the threefold concentrated lavage
samples were transferred into 15x1.6 cm centrifuge tubes
and 5 ml of 5% trichloroacetic acid added drop by drop
whilst shaking. The samples were centrifuged for 20
min at 2,500 rpm. The supematants were discarded, and
1 ml of digestion mixture (500 µl distilled water, 250 µl
c ncentrated sulphuric acid and 250 µl perchloric acid
(s.g. 1.75) was added to the deposit in each tube and
heated gently for 30-45 min, until the liquids become
colourless. The samples were allowed to cool. One mil-
lilitre of distilled water was added to each sample and
boiled for 15 s to convert pyrophosphate to orthophos-
phate. One millilitre of 50% sodium acetate was added
and made up to 10 ml with distilled water. Then, 1 ml
of 2.5% ammonium molybdate and 1 ml of 1% metol
in 3% sodium hydrogen sulphite solution was added and
mixed well. After 15 min, the reaction mixtures were
read at 700 nm in a spectrophotometer, against a reagent
blank prepared by mixing 250 µl concentrated sulphuric
acid, 1 ml sodium acetate, 1 ml molybdate, 1 ml metol
and 8.75 ml distilled water.
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A stock standard solution, 30 mmol-l-1 concentration
of potassium dihydrogen orthophosphate (KH2PO4) was
prepared, in double distilled water containing 2 ml con-
centrated sulphuric acid. A working standard of 0.12
mmol-l-1 was prepared from stock standard (30 mmol-l-1)
by diluting the stock standard 1 to 250 with distilled
water. Five ml of working standard (0.12 mmol-l-1) was
added with 250 µl concentrated sulphuric acid, 1 ml
molybdate, 1 ml sodium acetate, 1 ml metol and 3.75
ml distilled water, and read against the reagent blank.
Lavage phospholipid phosphorous was calculated as
described below:
Reading of lavage sample 5ml x 0.12 mmol            1 ml
X X                                      X  1000 ml
Reading of working standard1000 ml 0.2 ml
Reading of lavage sample
x 3 mmol-l-1 or 9.3 mg-dl-1
Reading of working standard
(3 mmol-l-1 = 93 mg-l-1)
For a standard curve, the stock standard (30 mmol-l-1)
was diluted from 1 to 150 to give a solution containing
0.20 mmol-l-1. Zero, 1, 2, 3, 4 and 5 ml of this was ad-
ded sulphuric acid, acetate, molybdate and metol as men-
tioned above, and made up to 10 ml with distilled water.
These are equivalent to 0, 1, 2, 3, 4 and 5 mmol-l-1. (3.1,
6.2, 9.3, 12.4 and 15.5 mg.dl-1).
Statistical methods
The results are expressed as arithmetical or geometri-
cal mean±SE, wherever applicable. Statistical analysis
was performed using Students t-test.
Results
The mean percentage fluid during BAL was more than
50% of the saline infused in active pulmonary tubercu-
losis (ATB), inactive tuberculosis (cured) (ITB) patients
and healthy subjects (table 1). The lavage fluids of ATB,
ITB and normal subjects were equally competent in their
S. aureus killing activity at 0 and 2 h. In normal and
ITB lavage samples, increased killing activity was observed
with increased incubation time. However, the bacteri-
cidal activity against S. aureus was reduced at 4 h in the
ATB lavage fluids compared to normal and ITB (fig. 1).
In order to determine the effect of smoking on the
bactericidal activity against S. aureus, the results at 4 h
incubation were analysed separately for nonsmokers and
smokers; this revealed that smoking has no significant
effect on the bactericidal activity of the lavage fluids
(data not shown).
Active tuberculous and inactive tuberculous lavage
fluids had significantly increased total cell numbers, com-
pared to normal subjects (p<0.01 and p<0.05, respectiv-
ely). Furthermore, a decrease in the percentage macrophages
(p<0.01) and increase in lymphocytes (p<0.005) was seen
in the ATB lavage fluids compared to normal. This dif-
ference in the macrophage and lymphocyte count was
Fig. 1. - Bactericidal activity against S. aureus of bronchoalveolar
lavage fluids (threefold concentrated) of: • normal individuals
(n=6); • : active tuberculosis patients (n=13); and  o  : inac-
tive tuberculosis patients (n=8). Percentage S. aureus killing was mea-
sured at different time points.Data are presented as geometric means±SE.
Table. 1. - Percentage fluid recovery, total and differential cell counts and phospholipid levels of alveolar
lavage fluids of normal individuals, and patients with active and inactive tuberculosis (TB)
Differential counts
Group Fluid
recovery
%
Total
cells
x 107-l-1
Mac Lymph
% %
Neut
%
Eos
%
PL$
levels
mgdl-1
Normals 59±2 22±2 84±2 15±3 1±1 l±0 0.40±0.10
n=6
ATB 58±3 51±9* 66±5** 31±5*** 2±1 1±0 0.47±0.11
n=13
ITB 53±4 56±16# 77±6 19±5 3±1 1±1 0.79±0.28
n=8
Data are presented as mean±SE. ATB: patients with active TB; ITB: patients with inactive TB; Mac: macrophages;
Lymph: lymphocytes; Neut: neutrophils; Eos: eosinophils; PL: phospholipid level. Normal vs ATB: *: p<0.01;
**: p<0.01; ***: p<0.005. Normal vs ITB: #: p<0.05.$: phospholipid level in 1 x lavage fluid (unconcentrated).
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not seen in ITB lavage fluids. A slightly higher level
of total phospholipid in ATB and a considerable increase
in ITB lavage fluids was seen compared to normal lavage
fluids (table 1). Based on the percentage lymphocytes
(and macrophages) of normal subjects (cut-off point 20%
lymphocytes), the ATB and ITB patients were divided
into no lymphocytic alveolitis (<20% lymphocytes) and
lymphocytic alveolitis (>20% lymphocytes) groups. There
was no difference in the total phospholipid levels between
“no lymphocytic alveolitis” and “lymphocytic alveolitis”
groups (table 2).
In normal subjects and ITB patients, a maximum bacte-
ricidal activity (67-72%) against S. aureus was observed
at 0.4 and 0.79 mg.dl-1 (mean values) concentration of
phospholipids in the lavage fluids (unconcentrated). Even
though the phospholipid level (mean value) of ATB
lavage was closer to normals, the bactericidal activity
was low (32%) compared to normals. Increase in total
phospholipid level had no effect on the bactericidal activ-
ity of the active tuberculous lavage fluids (fig. 2). The
bactericidal activity against S. aureus of lavage fluids of
normal subjects, ATB and ITB was not much influenced
by the total phospholipid levels. However, the killing
activity was influenced by the increased lymphocytes
(and decreased macrophages) (fig. 3).
The lavage fluids of normal subjects and ITB patients
with no lymphocytic alveolitis showed an increased killing
of S. aureus. On the other hand, ATB lavage fluids with
no lymphocytic alveolitis showed a considerably decrea-
sed bactericidal activity against S. aureus. An increased
trend on bactericidal activity was seen in the ATB and
ITB lavage fluids with lymphocytic alveolitis (>20%
lymphocytes) (fig. 3).
All lavage fluids were screened for the presence of
antibodies against S. aureus, and found to be negative,
except for one inactive tuberculous and one normal lavage
fluid (titre 1:2). The lavage fluids were also cultured to
detect the presence of S. aureus and other bacteria. Only
one ATB lavage fluid showed 26 cfu of S. aureus. One
normal, one ATB and two ITB fluids showed growth of
Table. 2. - Percentage lymphocytes and total phos-
pholipid levels in the lavage fluids of normal subjects and
patients with no lymphocytic alveolitis and lymphocytic
alveolitis
Fig. 2. - Effect of phospholipid levels on S. aureus killing activity
of: -• normal (NOR); • : active tuberculous (ATB); and O : inac-
tive tuberculous (ITB) lavage fluids. Percentage S. aureus killed at 4
h time-point is presented. Arrow marks with dotted lines represent the
mean values of total phospholipid levels and the corresponding bacte-
ricidal activities against S. aureus.
Fig. 3. - Relationship between lymphocytes and S. aureus killing activ-
ity with correlation lines (simple linear regression). Bactericidal activi-
ty at 4 h time point is presented. •: normal (NOR); • : patient with
active tuberculosis (ATB); O : patient with inactive tuberculosis (ITB).
bacterial colonies other than S. aureus. However, the
bactericidal activity against S. aureus of the lavage sam-
ples was not affected.
Discussion
The cell-free supematants of alveolar lavage samples
of healthy subjects, ATB and ITB patients showed an
increasing bactericidal activity with increasing time of
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incubation. However, the bactericidal activity against S.
aureus of ATB was reduced at 4 h of incubation, com-
pared to the normal and ITB lavage samples (fig. 1).
The lavage fluids of normal and ITB were more effi-
cient in their killing activity against S. aureus than ATB.
This increased killing effect of normal and ITB lavage
fluids was not due to anti-staphylococcal antibody, since
almost all samples were negative for a detectable level
of antibodies. Furthermore, the killing effect of the ITB
lavage fluids was not due to anti-staphylococcal activi-
ty of rifampicin. The ITB patients included in this study
had received antituberculosis treatment at least one year
prior to our evaluation.
It has been shown that crude preparations of lung
lavage material possess intrinsic bactericidal activity [6,
7]. Moreover, the phospholipid-protein content of the
surfactant produced by the type-II epithelial cells of the
lung has been shown to contain this bactericidal activi-
ty. The bactericidal activity against S. aureus of the nor-
mal and ITB lavage samples observed in this study may
be due to the phospholipid-protein content of the sur-
factant. It has been well established that palmityl lysophos-
phatidylcholine (lysophospholipid) possesses anti-bacterial
activity against several Gram-positive bacteria [7]. Altered
levels of phospholipids have been shown in smoking
[12], and diseases such as bacterial pneumonia and idio-
pathic pulmonary fibrosis [13-15], and respiratory dis-
tress syndrome [13, 16]. Although smoking has been
shown to alter the surfactant level, the present study
showed no significant effect of smoking on the bacteri-
cidal activity of ATB and ITB lavage fluids.
The reduced bactericidal activity against S. ureus of
the ATB lavage was not due to the presence of S. aureus
in the lavage fluids. Out of 13 samples, one sample was
positive for S. aureus and the rest were negative. Even
though reduced levels of surfactant containing phos-
pholipids have been shown in ATB lung [17], in the pre-
sent study there was no difference in the level of total
phospholipid contents of normals, ATB and ITB lavage
fluids. In normal individuals, since the integrity of the
alveolar space is maintained, the phospholipid produc-
tion by the type II epithelial cells are probably regulat-
ed. A similar kind of phospholipid production can also
be expected in the ITB individuals. In ATB patients,
there may be macrophage lysis due to M. tuberculosis
multiplication, or lysis of M. tuberculosis nfected
macrophages by cytotoxic T-lymphocytes [18]. Phospholipid
contents of the lysed host cells [11, 19], and killed M.
tuberculosis [20], in the alveolar space would, thus, result
in increased total phospholipid contents of the alveolar
lining material. The present study suggests that the
reduced bactericidal activity in the lavage fluids of ATB
could not be due to the total phospholipid level of the
lavage fluids. An altered level of lysophospholipid which
(possesses antibacterial activity) in the total phospho-
lipid may be one possible factor involved in the reduced
bactericidal activity against S. aureus.
On the other hand, the bactericidal activity was influ-
enced by the cellular components of the lavage fluids
(lymphocytes and macrophages). A reduced bacterici-
dal activity against S. aureus was seen in ATB lavage
fluids with no lymphocytic alveolitis (<20% lympho-
cytes). However, a trend towards increased bactericidal
activity was seen in the ATB and ITB lavage fluids with
lymphocytic alveolitis (>20% lymphocytes). Several
human respiratory diseases have been shown to be asso-
ciat d with pulmonary lymphocytic infiltration and alveo-
litis [21]. The association of bactericidal activity and
the l vel of cellular components could be due to the
interaction of lymphocytes and alveolar macrophages
wi h alveolar type-II epithelial cells, resulting in the pro-
d ction of a decreased level of the lysophospholipid in
the total phospholipid content of the surfactant.
The present study, thus, reveals that the reduced bac-
tericidal activity against S. aureus of the alveolar lining
material of ATB lavage may be a transient effect. When
the disease (active tuberculosis) progresses, the level of
pulmonary defence against bacterial infections, such as
S. aureus, may be lowered. Infiltration of cellular com-
ponents, such as lymphocytes and other cells, into the
alveolar microenvironment may probably be involved in
reg lating the pulmonary defence mechanism against
such infections. Treatment with antituberculosis drugs
restores the pulmonary defence mechanism against bac-
terial infections, such as those caused by staphylococci.
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